beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene

Akar, Sakine; ALTUNTAŞ, HAMİYET; HAMURCU, ZÜHAL

doi:10.1007/s11033-022-07536-5

beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene

Akar S., ALTUNTAŞ H. , HAMURCU Z.

MOLECULAR BIOLOGY REPORTS, 2022 (Journal Indexed in SCI)

Publication Type: Article / Article
Publication Date: 2022
Doi Number: 10.1007/s11033-022-07536-5
Title of Journal : MOLECULAR BIOLOGY REPORTS
Keywords: Apoptosis, ASCT2, Breast cancer, beta-Escin, Glutamine, GLS1, Migration, c-myc, MDA-MB-231, BREAST-CANCER, SUPPRESSES PROLIFERATION, IN-VITRO, KAPPA-B, APOPTOSIS, RESISTANCE, MIGRATION, INVASION, GEMCITABINE, EXPRESSION

Abstract

Background The c-myc oncogene, which causes glutamine dependence in triple negative breast cancers (TNBC), is also the target of one of the signaling pathways affected by beta-Escin.